"Watch the live broadcast at either of the following links:

• Broadband Connection
• Slower Connection

This session of Grand Rounds will explore a High-Impact Prevention approach to prevent HIV in the United States. Because HIV incidence is stable and effective treatment exists to prevent illness and death, a growing number of persons—over 1.1 million—are living with HIV. Nearly one in five of those are not aware that they are infected. Continued growth in the number of people living with HIV—especially those unaware of their infection—ultimately may lead to more infections, if prevention, care and treatment are not targeted to those at greatest risk. At the same time, recent scientific breakthroughs in treatment, prevention, and monitoring of this disease have equipped us with an unprecedented number of effective tools to prevent infection. To maximize reductions in HIV infections, High-Impact Prevention seeks to effectively distribute limited resources and combine prevention strategies in the smartest and most effective way possible for the populations and areas most affected by the HIV epidemic.

Please join us for this session of Grand Rounds in which we will explore the science behind High-Impact HIV Prevention. New directions in monitoring the burden of HIV and resource allocation modeling of HIV prevention interventions will be presented as well as the White House’s ongoing implementation of the National HIV/AIDS Strategy to improve HIV prevention and care.

Presented By

Jonathan Mermin, MD, MPH
Director, Division of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC
“Science of Optimizing HIV Prevention”

Irene Hall, PhD, FACE
Chief, HIV Incidence and Case Surveillance Branch, Division of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC
“New Directions in Monitoring the Burden of HIV”

Stephanie Sansom, PhD, MPP, MPH
Commander, U.S. Public Health Service
Lead, Prevention Economics Team
Quantitative Sciences and Data Management Branch, Division of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC
“Modeling to Identify Optimal Allocation of HIV Prevention Resources in a City Health Department”

Grant Colfax, MD, MPH
Director, Office of National AIDS Policy
The White House
“Ongoing Implementation of the National HIV/AIDS Strategy to Improve HIV Prevention and Care”

Facilitated By:

Tanja Popovic, MD, PhD, Scientific Director, Public Health Grand Rounds

John Iskander, MD, MPH, Deputy Scientific Director, Public Health Grand Rounds

Susan Laird, MSN, RN, Communications Manager, Public Health Grand Rounds